99 related articles for article (PubMed ID: 20037485)
1. Synergistic action of doxorubicin and sulindac in human cervix carcinoma cells - studies on possible mechanisms.
Gruber BM; Bubko I; Krzyszton-Russjan J; Anuszewska EL
Med Sci Monit; 2010 Jan; 16(1):BR45-51. PubMed ID: 20037485
[TBL] [Abstract][Full Text] [Related]
2. Possible role of HSP60 in synergistic action of anthracyclines and sulindac in HeLa cells.
Gruber BM; Krzysztoń-Russjan J; Bubko I; Anuszewska EL
Acta Pol Pharm; 2010; 67(6):620-4. PubMed ID: 21229877
[TBL] [Abstract][Full Text] [Related]
3. Modulation of apoptosis protein profiles--role of P-gp in HeLa cells exposed to doxorubicin.
Gruber BM; Krzysztoń-Russjan J; Bubko I; Koronkiewicz M; Anuszewska EL
Cancer Genomics Proteomics; 2012; 9(3):153-61. PubMed ID: 22593250
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of P-glycoprotein 1 (Pgp1, ABCB1)-mediated doxorubicin-resistant PLHC-1 hepatoma fish cell line.
Zaja R; Caminada D; Loncar J; Fent K; Smital T
Toxicol Appl Pharmacol; 2008 Mar; 227(2):207-18. PubMed ID: 18076962
[TBL] [Abstract][Full Text] [Related]
6. Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells.
Minko T; Batrakova EV; Li S; Li Y; Pakunlu RI; Alakhov VY; Kabanov AV
J Control Release; 2005 Jul; 105(3):269-78. PubMed ID: 15939500
[TBL] [Abstract][Full Text] [Related]
7. Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Ji BS; He L; Liu GQ
Life Sci; 2005 Sep; 77(18):2221-32. PubMed ID: 15967469
[TBL] [Abstract][Full Text] [Related]
8. [Somatostatin enhanced anti-tumor effect of doxorubicin on gallbladder cancer cells through the regulation of intracellular drug concentration].
Gong W; Qin YY; Li SG; Quan ZW; Li JY; Zhuang PY; Wan ZW
Zhonghua Yi Xue Za Zhi; 2010 Oct; 90(38):2718-22. PubMed ID: 21162905
[TBL] [Abstract][Full Text] [Related]
9. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.
Shaik MS; Chatterjee A; Singh M
J Pharm Pharmacol; 2004 Jul; 56(7):899-907. PubMed ID: 15233869
[TBL] [Abstract][Full Text] [Related]
10. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
11. Sulindac induces specific degradation of the HPV oncoprotein E7 and causes growth arrest and apoptosis in cervical carcinoma cells.
Karl T; Seibert N; Stöhr M; Osswald H; Rösl F; Finzer P
Cancer Lett; 2007 Jan; 245(1-2):103-11. PubMed ID: 16488075
[TBL] [Abstract][Full Text] [Related]
12. Bcl-2 and mdr-1 gene expression during doxorubicin-induced apoptosis in murine leukemic P388 and P388/R84 cells.
Ramachandran C; You W; Krishan A
Anticancer Res; 1997; 17(5A):3369-76. PubMed ID: 9413174
[TBL] [Abstract][Full Text] [Related]
13. Medicarpin and millepurpan, two flavonoids isolated from Medicago sativa, induce apoptosis and overcome multidrug resistance in leukemia P388 cells.
Gatouillat G; Magid AA; Bertin E; El btaouri H; Morjani H; Lavaud C; Madoulet C
Phytomedicine; 2015 Dec; 22(13):1186-94. PubMed ID: 26598918
[TBL] [Abstract][Full Text] [Related]
14. Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: possible link to apoptosis.
Bottone FG; Martinez JM; Collins JB; Afshari CA; Eling TE
J Biol Chem; 2003 Jul; 278(28):25790-801. PubMed ID: 12734198
[TBL] [Abstract][Full Text] [Related]
15. Increased anti-tumour efficacy of doxorubicin when combined with sulindac in a xenograft model of an MRP-1-positive human lung cancer.
O'Connor R; Heenan M; Connolly L; Larkin A; Clynes M
Anticancer Res; 2004; 24(2A):457-64. PubMed ID: 15152944
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of glutathione-related genes, enzyme activities and transport proteins in human cervical cancer cells treated with doxorubicin.
Drozd E; Krzysztoń-Russjan J; Marczewska J; Drozd J; Bubko I; Bielak M; Lubelska K; Wiktorska K; Chilmonczyk Z; Anuszewska E; Gruber-Bzura B
Biomed Pharmacother; 2016 Oct; 83():397-406. PubMed ID: 27424321
[TBL] [Abstract][Full Text] [Related]
17. Parthenolide reverses doxorubicin resistance in human lung carcinoma A549 cells by attenuating NF-κB activation and HSP70 up-regulation.
Xin Y; Yin F; Qi S; Shen L; Xu Y; Luo L; Lan L; Yin Z
Toxicol Lett; 2013 Aug; 221(2):73-82. PubMed ID: 23792430
[TBL] [Abstract][Full Text] [Related]
18. Non-steroidal anti-inflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and -5 induction, which may explain sulindac sulfide induced gastric cancer cell apoptosis.
Jang TJ; Kang HJ; Kim JR; Yang CH
Carcinogenesis; 2004 Oct; 25(10):1853-8. PubMed ID: 15180942
[TBL] [Abstract][Full Text] [Related]
19. Lack of correlation of MRP and gamma-glutamylcysteine synthetase overexpression with doxorubicin resistance due to increased apoptosis in SV40 large T-antigen-transformed human mesothelial cells.
Ogretmen B; Bahadori H; McCauley M; Boylan A; Green M; Safa AR
Cancer Chemother Pharmacol; 1998; 42(6):441-6. PubMed ID: 9788569
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of P-glycoprotein and increasing of drug-sensitivity of a human carcinoma cell line (KB-A-1) by an antisense oligodeoxynucleotide-doxorubicin conjugate in vitro.
Ren Y; Wei D; Zhan X
Biotechnol Appl Biochem; 2005 Apr; 41(Pt 2):137-43. PubMed ID: 15202936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
